Inactivated COVID-19 vaccine BBV152/COVAXIN effectively neutralizes recently emerged B.1.1.7 variant of SARS-CoV-2

被引：81
|
作者：
Sapkal, Gajanan N. [1 ]
Yadav, Pragya D. [1 ]
Ella, Raches [2 ]
Deshpande, Gururaj R. [1 ]
Sahay, Rima R. [1 ]
Gupta, Nivedita [3 ]
Vadrevu, Krishna Mohan [2 ]
Abraham, Priya [1 ]
Panda, Samiran [3 ]
Bhargava, Balram [3 ]
机构：
[1] Indian Council Med Res, Natl Inst Virol, Pune 411021, Maharashtra, India
[2] Bharat Biotech Int Ltd, Genome Valley, Hyderabad 500078, Telangana, India
[3] Indian Council Med Res, V Ramalingaswami Bhawan, POB 4911, New Delhi 110029, India
来源：
JOURNAL OF TRAVEL MEDICINE | 2021年 / 28卷 / 04期
关键词：
SARS-CoV-2; N501Y; escape mutants; vaccine efficacy; neutralization; variant of concern;
D O I：
10.1093/jtm/taab051
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
[No abstract available]
引用
收藏
页数：3
相关论文
共 37 条
  • [21] Fast forward evolution in real time: the rapid spread of SARS-CoV-2 variant of concern lineage B.1.1.7 in Saxony-Anhalt over a period of 5 months
    Glass, Markus
    Misiak, Danny
    Misiak, Claudia
    Muller, Simon
    Rausch, Alexander
    Angermann, Katharina
    Hoyer, Mariann
    Zabel, Ramona
    Kehlen, Astrid
    Mobius, Beate
    Weickert, Jessica
    Huttelmaier, Stefan
    Karrasch, Matthias
    JOURNAL OF LABORATORY MEDICINE, 2022, 46 (01) : 71 - 75
  • [22] COVID-19 Challenge: A Quest for Effective Vaccine Strategies Against Circulating and Emerging SARS-CoV-2 Variants
    Yogesh, Ruchika
    Srivastava, Noopur
    Bukhari, Syed Nasir Abbas
    CURRENT PHARMACEUTICAL DESIGN, 2022, 28 (35) : 2901 - 2913
  • [23] A Live Attenuated COVID-19 Candidate Vaccine for Children: Protection against SARS-CoV-2 Challenge in Hamsters
    Mehla, Rajeev
    Kokate, Prasad
    Bhosale, Sarika R.
    Vaidya, Vivek
    Narayanan, Shridhar
    Shandil, Radha. K.
    Singh, Mayas
    Rudramurthy, Gudepalya R.
    Naveenkumar, Chakenahalli N.
    Bharathkumar, Kumaraswamy
    Coleman, Rob
    Mueller, Steffen
    Dhere, Rajeev M.
    Yeolekar, Leena R.
    VACCINES, 2023, 11 (02)
  • [24] Identification, propagation and molecular characterization of SARS-CoV-2 delta variant isolated from Egyptian COVID-19 patients
    Alotaibi, Badriyah
    El-Masry, Thanaa A.
    Seadawy, Mohamed G.
    El-Harty, Bassem E.
    Saleh, Asmaa
    Gad, Ahmed F.
    El-Hosseny, Mostafa F.
    Mahran, Yasmen F.
    El-Bouseary, Maisra M.
    INFECTION GENETICS AND EVOLUTION, 2022, 100
  • [25] Viral Load in COVID-19 Patients: Implications for Prognosis and Vaccine Efficacy in the Context of Emerging SARS-CoV-2 Variants
    da Silva, Severino Jefferson Ribeiro
    de Lima, Suelen Cristina
    da Silva, Ronaldo Celerino
    Kohl, Alain
    Pena, Lindomar
    FRONTIERS IN MEDICINE, 2022, 8
  • [26] Serosurvey in BNT162b2 vaccine-elicited neutralizing antibodies against authentic B.1, B.1.1.7, B.1.351, B.1.525 and P.1 SARS-CoV-2 variants
    Zani, Alberto
    Caccuri, Francesca
    Messali, Serena
    Bonfanti, Carlo
    Caruso, Arnaldo
    EMERGING MICROBES & INFECTIONS, 2021, 10 (01) : 1241 - 1243
  • [27] Cytomegalovirus-vectored COVID-19 vaccines elicit neutralizing antibodies against the SARS-CoV-2 Omicron variant (BA.2) in mice
    Liu, Jian
    Jaijyan, Dabbu Kumar
    Chen, Yanling
    Feng, Changcan
    Yang, Shaomin
    Xu, Zhenglong
    Zhan, Nichun
    Hong, Congming
    Li, Shuxuan
    Cheng, Tong
    Zhu, Hua
    MICROBIOLOGY SPECTRUM, 2023,
  • [28] Molecular Analysis of SARS-CoV-2 Genetic Lineages in Jordan: Tracking the Introduction and Spread of COVID-19 UK Variant of Concern at a Country Level
    Sallam, Malik
    Mahafzah, Azmi
    PATHOGENS, 2021, 10 (03): : 1 - 12
  • [29] The Barriers, Challenges, and Strategies of COVID-19 (SARS-CoV-2) Vaccine Acceptance: A Concurrent Mixed-Method Study in Tehran City, Iran
    Khankeh, Hamid Reza
    Farrokhi, Mehrdad
    Khanjani, Mohammad Saeed
    Momtaz, Yadollah Abolfathi
    Forouzan, Ameneh Setareh
    Norouzi, Mehdi
    Ahmadi, Shokoufeh
    Harouni, Gholamreza Ghaedamini
    Roudini, Juliet
    Ghanaatpisheh, Elham
    Hamedanchi, Arya
    Pourebrahimi, Mohammad
    Alipour, Fardin
    Ranjbar, Maryam
    Naghikhani, Mehrdad
    Saatchi, Mohammad
    VACCINES, 2021, 9 (11)
  • [30] Emergence of SARS-CoV-2 Omicron (B.1.1.529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic
    Khandia, Rekha
    Singhal, Shailja
    Alqahtani, Taha
    Kamal, Mohammad Amjad
    El-Shall, Nahed A.
    Nainu, Firzan
    Desingu, Perumal Arumugam
    Dhama, Kuldeep
    ENVIRONMENTAL RESEARCH, 2022, 209
1234